Financial results - QUEISSER PHARMA SRL

Financial Summary - Queisser Pharma Srl
Unique identification code: 32420207
Registration number: J2013013477406
Nace: 4638
Sales - Ron
19.558.076
Net Profit - Ron
1.009.622
Employees
45
Open Account
Company Queisser Pharma Srl with Fiscal Code 32420207 recorded a turnover of 2024 of 19.558.076, with a net profit of 1.009.622 and having an average number of employees of 45. The company operates in the field of Comerţ cu ridicata specializat al altor alimente having the NACE code 4638.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Queisser Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 5.925.246 7.286.442 7.663.827 8.965.659 11.507.794 13.486.188 16.394.124 16.009.769 15.497.526 19.558.076
Total Income - EUR 6.384.579 7.886.255 7.732.642 9.040.196 11.550.671 13.562.001 16.537.024 16.215.141 15.710.773 19.697.793
Total Expenses - EUR 5.771.330 6.845.779 7.312.475 8.309.261 10.511.873 12.258.823 14.861.853 14.600.612 14.597.860 18.494.956
Gross Profit/Loss - EUR 613.249 1.040.476 420.167 730.935 1.038.798 1.303.177 1.675.172 1.614.529 1.112.914 1.202.837
Net Profit/Loss - EUR 496.124 844.148 326.324 601.318 856.317 1.060.615 1.398.863 1.415.304 911.569 1.009.622
Employees 26 30 35 37 39 42 40 39 38 45
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 26.9%, from 15.497.526 euro in the year 2023, to 19.558.076 euro in 2024. The Net Profit increased by 103.147 euro, from 911.569 euro in 2023, to 1.009.622 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Queisser Pharma Srl

Rating financiar

Financial Rating -
QUEISSER PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Queisser Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Queisser Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Queisser Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Queisser Pharma Srl - CUI 32420207

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 49.650 43.019 36.097 51.391 59.048 90.775 86.722 107.565 192.592 224.931
Current Assets 4.831.268 4.943.295 5.233.537 5.651.454 7.139.359 8.530.683 10.648.131 11.128.895 11.848.994 13.805.100
Inventories 645.856 496.277 860.002 872.825 2.116.236 2.140.522 2.328.241 2.414.617 2.302.189 3.107.938
Receivables 3.088.126 3.656.630 3.639.765 4.305.835 4.247.778 5.996.228 7.793.742 7.091.174 7.178.430 8.417.107
Cash 1.097.286 790.388 733.770 472.795 775.345 393.934 526.147 1.623.105 2.368.374 2.280.055
Shareholders Funds 1.257.501 1.988.619 2.681.782 3.018.993 3.606.113 4.335.810 5.335.296 6.553.222 7.222.540 7.890.246
Social Capital 299.667 296.611 692.082 679.381 666.224 653.594 639.100 641.083 639.139 635.567
Debts 3.624.391 2.937.424 2.580.617 2.614.091 3.446.325 3.942.551 4.771.918 4.285.506 4.321.687 5.783.766
Income in Advance 1.559 4.482 6.594 4.201 3.203 7.376 7.481 8.387 6.632 6.354
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4638 - 4638"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 13.805.100 euro in 2024 which includes Inventories of 3.107.938 euro, Receivables of 8.417.107 euro and cash availability of 2.280.055 euro.
The company's Equity was valued at 7.890.246 euro, while total Liabilities amounted to 5.783.766 euro. Equity increased by 708.072 euro, from 7.222.540 euro in 2023, to 7.890.246 in 2024. The Debt Ratio was 42.3% in the year 2024.

Risk Reports Prices

Reviews - Queisser Pharma Srl

Comments - Queisser Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.